Canopus Biopharma Incorporated Stock Volatility Indicators Average True Range

CBIA Stock  USD 0.0001  0.0001  50.00%   
Canopus BioPharma volatility indicators tool provides the execution environment for running the Average True Range indicator and other technical functions against Canopus BioPharma. Canopus BioPharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volatility indicators indicators. As with most other technical indicators, the Average True Range indicator function is designed to identify and follow existing trends. Canopus BioPharma volatility indicators enable investors to predict price movements based on how different True Range indicators change over time. Please specify Time Period to run this model.

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Canopus BioPharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Canopus BioPharma Technical Analysis Modules

Most technical analysis of Canopus BioPharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Canopus from various momentum indicators to cycle indicators. When you analyze Canopus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Canopus BioPharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Canopus BioPharma Incorporated. We use our internally-developed statistical techniques to arrive at the intrinsic value of Canopus BioPharma Incorporated based on widely used predictive technical indicators. In general, we focus on analyzing Canopus Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Canopus BioPharma's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Canopus BioPharma's intrinsic value. In addition to deriving basic predictive indicators for Canopus BioPharma, we also check how macroeconomic factors affect Canopus BioPharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Hype
Prediction
LowEstimatedHigh
0.000.00008642.59
Details
Intrinsic
Valuation
LowRealHigh
0.000.00008242.59
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in Canopus Pink Sheet

Canopus BioPharma financial ratios help investors to determine whether Canopus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Canopus with respect to the benefits of owning Canopus BioPharma security.